Literature DB >> 32965543

Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma.

Yujing Sun1, Junyi He2, Duan-Bo Shi2, Hui Zhang2, Xu Chen2, Ai-Yan Xing2, Peng Gao3,4.   

Abstract

PURPOSE: Tumor budding (TB) is reported to predict nodal involvement and recurrence in multiple human malignancies. However, it is not clear how TB forms. The purpose of this study is to find markers related to TB formation in gastric cancer and to investigate the underlying mechanisms.
METHODS: TB was scored on hematoxylin-eosin staining slides in 122 gastric cancer cases. Immunostaining score of CREB1, GAGE12I, CTNND1, KIF26B and ZBTB7A both at the invasive front and in the center of the tumor were assigned to each case. Spearman's correlation with the TB score was performed to find the TB-related markers. In vitro study and RNA-seq using gastric cancer cell lines were done to unveil the mechanisms.
RESULTS: TB could predict lymph node metastasis and is negatively associated with overall survival of the patients. The expression of ZBTB7A in the invasive front, rather than the other four markers, was much higher than that in the tumor center and was positively correlated with TB score. ZBTB7A could enhance migration and invasion of gastric cancer cells in vitro. RNA-seq data followed by RT-qPCR and western blot verification demonstrated the activation of EGFR-MAPK-ERK and PI3K-AKT-mTOR pathways and increased expression of EMT related markers upon ZBTB7A over-expression.
CONCLUSION: Higher ZBTB7A expression in the tumor margin may contribute to the dissociation of tumor cells from the tumor mass to form TB by initiating EMT via EGFR-MEK-ERK and PI3K-AKT-mTOR pathway.

Entities:  

Keywords:  Epithelial-mesenchymal transition; Gastric carcinoma; Metastasis; Tumor budding; ZBTB7A

Year:  2020        PMID: 32965543     DOI: 10.1007/s00432-020-03388-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  28 in total

Review 1.  Tumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colon.

Authors:  Kyra B Berg; David F Schaeffer
Journal:  Mod Pathol       Date:  2018-02-06       Impact factor: 7.842

Review 2.  The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

Authors:  Antonella De Luca; Monica R Maiello; Amelia D'Alessio; Maria Pergameno; Nicola Normanno
Journal:  Expert Opin Ther Targets       Date:  2012-03-23       Impact factor: 6.902

3.  Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.

Authors:  Eva Karamitopoulou; Inti Zlobec; Ioannis Panayiotides; Efstratios S Patsouris; George Peros; George Rallis; Christos Lapas; Petros Karakitsos; Luigi M Terracciano; Alessandro Lugli
Journal:  Hum Pathol       Date:  2011-06-12       Impact factor: 3.466

4.  Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.

Authors:  Eva Karamitopoulou; Alessandro Lugli; Ioannis Panayiotides; Petros Karakitsos; George Peros; George Rallis; Efstratios S Patsouris; Luigi Terracciano; Inti Zlobec
Journal:  Histopathology       Date:  2010-08       Impact factor: 5.087

5.  Tumor Budding Is Independently Predictive for Lymph Node Involvement in Early Gastric Cancer.

Authors:  Mine Gulluoglu; Gulcin Yegen; Yasemin Ozluk; Metin Keskin; Serap Dogan; Gökçen Gundogdu; Semen Onder; Emre Balik
Journal:  Int J Surg Pathol       Date:  2015-04-24       Impact factor: 1.271

6.  Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front.

Authors:  Rikke Karlin Jepsen; Guy Wayne Novotny; Louise Laurberg Klarskov; Claus Heiner Bang-Berthelsen; Ida Trondhjem Haakansson; Anker Hansen; Ib Jarle Christensen; Lene Buhl Riis; Estrid Høgdall
Journal:  Hum Pathol       Date:  2018-06-11       Impact factor: 3.466

7.  Tumor-cell dissociation at the invasion front: a new prognostic parameter in gastric cancer patients.

Authors:  H E Gabbert; S Meier; C D Gerharz; G Hommel
Journal:  Int J Cancer       Date:  1992-01-21       Impact factor: 7.396

8.  Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

Authors:  J A Galván; I Zlobec; M Wartenberg; A Lugli; B Gloor; A Perren; E Karamitopoulou
Journal:  Br J Cancer       Date:  2015-05-19       Impact factor: 7.640

9.  Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.

Authors:  Linde De Smedt; Sofie Palmans; Daan Andel; Olivier Govaere; Bram Boeckx; Dominiek Smeets; Eva Galle; Jasper Wouters; David Barras; Madeleine Suffiotti; Jeroen Dekervel; Thomas Tousseyn; Gert De Hertogh; Hans Prenen; Sabine Tejpar; Diether Lambrechts; Xavier Sagaert
Journal:  Br J Cancer       Date:  2016-11-24       Impact factor: 7.640

10.  Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma.

Authors:  Keying Che; Yang Zhao; Xiao Qu; Zhaofei Pang; Yang Ni; Tiehong Zhang; Jiajun Du; Hongchang Shen
Journal:  Onco Targets Ther       Date:  2017-02-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.